New wave of GLP-1 drugs is coming–and they're stronger than Wegovy and Zepbound

9 pointsposted 8 hours ago
by randycupertino

1 Comments

fcpk

3 hours ago

retrarutride has significant more Gip activity than known drugs. it also has the glucagon receptor activity that raises heartbeat of a large amount (10bpm at typical doses). I wouldn't be surprised it has more side effects if taking long term than the "milder glp1" drugs.